Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer - Concepedia

Concepedia

Publication | Open Access

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

DOI Full Paper Access

186

Citations

15

References

2014

Year

Mitesh J. Borad, Shantan Reddy, Nathan Bahary, Hope E. Uronis, Darren Sigal, Allen Lee Cohn, William R. Schelman, Joe Stephenson, E. Gabriela Chiorean, Peter J. Rosen,

Journal of Clinical Oncology

Abstract

PFS, tumor response, and CA 19-9 response were significantly improved with G+TH-302. G+T340 is being investigated further in the phase III MAESTRO study (NCT01746979).

References

	Year	Citations

Page 1